ODTX
ODTX clinical trials: Odyssey Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Odyssey Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
ODTX on the catalyst calendar · ODTX registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 2026Sponsor estimate | NCT07900607The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male ParticipantsOdyssey Therapeutics, Inc. · Health Volunteers | ODTXLead | Phase 1 | Recruiting | Locked | Locked | Locked |
| Apr 2026Sponsor estimate | NCT06850727Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative ColitisOdyssey Therapeutics, Inc. · Ulcerative Colitis (UC) | ODTXLead | Phase 2 | Recruiting | Locked | Locked | Locked |
| Nov 25, 2024Actual | NCT06206811Phase 1 Study to Investigate OD-07656 in Healthy Adult ParticipantsOdyssey Therapeutics, Inc. · Inflammatory Bowel Diseases | ODTXLead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Dec 2026Sponsor estimatePhase 1NCT07900607The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male ParticipantsOdyssey Therapeutics, Inc. · Health VolunteersRecruitingODTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2026Sponsor estimatePhase 2NCT06850727Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative ColitisOdyssey Therapeutics, Inc. · Ulcerative Colitis (UC)RecruitingODTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 25, 2024ActualPhase 1NCT06206811Phase 1 Study to Investigate OD-07656 in Healthy Adult ParticipantsOdyssey Therapeutics, Inc. · Inflammatory Bowel DiseasesCompletedODTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner